activins has been researched along with Limb-Girdle Muscular Dystrophies in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fujino, M; Fukai, Y; Hagiwara, H; Hayashi, Y; Itoh, F; Murakami, T; Nishimatsu, S; Ohsawa, Y; Okada, T; Sunada, Y; Takayama, K; Tsuchida, K | 1 |
| Fujino, M; Hinohara, A; Ishizaki, M; Murakami, T; Nishimatsu, S; Noji, S; Ohsawa, Y; Okada, T; Shimizu, K; Shimizu, T; Suga, T; Sunada, Y; Tsuchida, K; Uchino, M | 1 |
2 other study(ies) available for activins and Limb-Girdle Muscular Dystrophies
| Article | Year |
|---|---|
The Inhibitory Core of the Myostatin Prodomain: Its Interaction with Both Type I and II Membrane Receptors, and Potential to Treat Muscle Atrophy.
Topics: Activins; Animals; Caveolin 3; Cell Differentiation; Cell Line; Cell Membrane Structures; Chlorocebus aethiops; COS Cells; Growth Differentiation Factors; HEK293 Cells; Humans; Ligands; Male; Mice; Muscle, Skeletal; Muscular Atrophy; Muscular Dystrophies, Limb-Girdle; Myoblasts; Myostatin; Protein Structure, Tertiary; Receptors, Cell Surface; Transforming Growth Factor beta1 | 2015 |
An inhibitor of transforming growth factor beta type I receptor ameliorates muscle atrophy in a mouse model of caveolin 3-deficient muscular dystrophy.
Topics: Activin Receptors, Type I; Activins; Animals; Caveolin 3; Cell Differentiation; Cell Line; Disease Models, Animal; Female; Gene Expression Regulation; HEK293 Cells; Humans; Male; Mice; Mice, Transgenic; Muscle Development; Muscle Fibers, Skeletal; Muscular Dystrophies, Limb-Girdle; Myoblasts; Myostatin; Protein Serine-Threonine Kinases; Receptor, Transforming Growth Factor-beta Type I; Receptors, Transforming Growth Factor beta; Satellite Cells, Skeletal Muscle; Signal Transduction; Transforming Growth Factor beta1 | 2012 |